BackCan-Fite Biopharma Overview

Can-Fite Biopharma Current Assets

Latest current assets for CANF: $9.4M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$9.44M
5.10% YoYΔ $458000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Can-Fite Biopharma Current Assets History

Loading

Can-Fite Biopharma vs. peers: Current Assets Comparison

Loading

Can-Fite Biopharma Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Can-Fite Biopharma (CANF) FAQ

As of the most recent data (December 2025), CANF shows a current assets of $9.4M. That compares with $9M in the prior-year period — up 5.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CANF's current assets is now $9.4M (was $9M) — a 5.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Can-Fite Biopharma is outperforming or lagging.

Tracking CANF's current assets over time shows whether Can-Fite Biopharma is scaling, shrinking, or reshaping that part of the business. The current reading is $9.4M That compares with $9M in the prior-year period — up 5.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Can-Fite Biopharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $9.4M) with ownership activity and broader fundamentals.

Can-Fite Biopharma's current assets is $9.4M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.